Sartorius Stedim Biotech SA / Key word (s): Quarter Results/Forecast Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 16-Apr-2025 / 07:00 CET/CEST ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has launched the single- use ultrafilter Sartocon® Slice 50. The new crossflow filter device is ...

[GOETTINGEN, Germany and GLASGOW, UK] / B3C newswire / — Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian ...

Guidance for 2025 EBITDA Margin: Expected between 29% to 30%. Sartorius Stedim Biotech SA (SDMHF) reported a strong start to 2025 with a 10% increase in sales revenue for Bioprocess Solutions ...

Sartorius Stedim Biotech reported its first-quarter 2025 results, exceeding company-compiled consensus estimates. Sales and adjusted EBITDA increased in constant currency by 10.4% and 19.9% ...

AUBAGNE, France - March 25, 2025 (NEWMEDIAWIRE) - At today's combined Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A., shareholders granted discharge to all Directors by a large ...

Sales revenue at 745 million euros, up 10.4 percent in constant currencies 1 (reported: 11.7 percent) Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, started the fiscal ...